BioLineRx (BLRX) Retained Earnings (2011 - 2026)
BioLineRx's Retained Earnings came in at -$405.63 million for the quarter ended Jun 30, 2026, compared with -$398.64 million a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Retained Earnings (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Retained Earnings was -$401 million.
- Going back by year, Retained Earnings was -$399.83 million in the year ended Dec 31, 2024, -$390.61 million in the year ended Dec 31, 2023, -$329.99 million in the year ended Dec 31, 2022 and -$305.04 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Retained Earnings in data going back to the quarter ended Sep 30, 2011.
- Business Quant data shows BLRX's Retained Earnings at -$402.6 million (quarter ended Mar 31, 2026), -$401 million (quarter ended Dec 31, 2025) and -$399.62 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 15.69 Bn |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | -405.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -405.63 Mn |
| Mar 31, 2026 | -402.60 Mn |
| Dec 31, 2025 | -401.00 Mn |
| Sep 30, 2025 | -399.62 Mn |
| Jun 30, 2025 | -398.64 Mn |
| Mar 31, 2025 | -394.70 Mn |
| Dec 31, 2024 | -399.83 Mn |
| Sep 30, 2024 | -396.64 Mn |
| Jun 30, 2024 | -390.82 Mn |
| Mar 31, 2024 | -391.30 Mn |
| Dec 31, 2023 | -390.61 Mn |
| Sep 30, 2023 | -376.72 Mn |
| Jun 30, 2023 | -360.70 Mn |
| Mar 31, 2023 | -342.15 Mn |
| Dec 31, 2022 | -329.99 Mn |
| Sep 30, 2022 | -324.26 Mn |
| Jun 30, 2022 | -317.41 Mn |
| Mar 31, 2022 | -309.97 Mn |
| Dec 31, 2021 | -305.04 Mn |
| Sep 30, 2021 | -300.74 Mn |
API Access
BioLineRx Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();